iPS derived cardiomyocytes as a tool to test the clinical significance and drug effectiveness in a novel mutation linked to CPVT
| Institution | Charité - Universitätsmedizin Berlin |
|---|---|
| Projektleiter | Felix Hohendanner |
| Standort | Berlin |
| Projektart | Shared Expertise (SE) |
| Fördersumme | € 29.821,00 |
| SE-Merkmal | SE-Partner |
| SE-Nummer | SE029 |
| Beginn | 01.07.2021 |
| Ende | 30.07.2023 |
| Partnerprojekte |
Förderkennzeichen
81X2100268
Projektnummer
1374